These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22836646)

  • 1. Immune response to influenza vaccine in hemodialysis patients with chronic renal failure.
    Mastalerz-Migas A; Steciwko A; Brydak LB
    Adv Exp Med Biol; 2013; 756():285-90. PubMed ID: 22836646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
    Petrie JG; Ohmit SE; Johnson E; Truscon R; Monto AS
    J Infect Dis; 2015 Dec; 212(12):1914-22. PubMed ID: 26014800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to influenza vaccination in healthy adults.
    Brydak LB; Tadeusz S; Magdalena M
    Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
    Couch RB; Atmar RL; Keitel WA; Quarles JM; Wells J; Arden N; Niño D
    Vaccine; 2012 Dec; 31(1):190-5. PubMed ID: 23107591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients.
    Mastalerz-Migas A; Bujnowska-Fedak M; Brydak LB
    Adv Exp Med Biol; 2015; 836():47-54. PubMed ID: 25248348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
    Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to influenza vaccination in an elderly population.
    Brydak LB; Machała M; Myśliwska J; Myśliwski A; Trzonkowski P
    J Clin Immunol; 2003 May; 23(3):214-22. PubMed ID: 12797543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to influenza vaccination in splenectomized patients in Poland.
    Brydak LB; Machała M; Łaguna P; Rokicka-Milewska R
    J Clin Immunol; 2004 May; 24(3):225-36. PubMed ID: 15114053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
    Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
    Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults.
    Antonen JA; Pyhälä R; Hannula PM; Ala-Houhala IO; Santanen R; Ikonen N; Saha HH
    Nephrol Dial Transplant; 2003 Apr; 18(4):777-81. PubMed ID: 12637648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequate seroresponse to influenza vaccination in dialysis patients.
    Antonen JA; Hannula PM; Pyhälä R; Saha HH; Ala-Houhala IO; Pasternack AI
    Nephron; 2000 Sep; 86(1):56-61. PubMed ID: 10971154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineuraminidase activity of inactivated influenza vaccines in elderly people].
    Burtseva EI; Vlasova LN; Slepushkin AN; Beliaev AL; Beregovskiĭ NA
    Vopr Virusol; 2002; 47(5):21-5. PubMed ID: 12522964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders.
    Brydak LB; Całbecka M
    Leuk Lymphoma; 1999 Jan; 32(3-4):369-74. PubMed ID: 10037036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.